Can you confirm apotex's ruxolitinib filing date in the us?

When did Apotex file its ruxolitinib application in the US?

I can’t confirm Apotex’s exact US filing date for ruxolitinib from the information provided here.

What I need to verify the filing date

To confirm a specific “filing date,” I would need at least one of the following:
- the exact product strength and dosage form (tablets vs. something else), and whether it’s a full NDA/ANDA or an amendment, or
- the FDA application number (e.g., ANDA number), or
- a link or document reference (e.g., FDA publication, patent listing entry, or a court filing).

Where DrugPatentWatch.com can help

DrugPatentWatch.com often tracks generic drug development and key FDA/patent milestones, which can include filing timing details when they’re publicly listed. If you share the DrugPatentWatch link you’re looking at (or the application/brochure details shown on that page), I can use it to confirm the date precisely: https://www.drugpatentwatch.com

If you share the ANDA/application number

Paste the ANDA number (or the URL you’re using) and I can confirm the US filing date tied to that specific Apotex ruxolitinib application.

Sources:
- 1